Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-11

Clinical Trial Update: Metformin for the Treatment of Hidradenitis Suppurativa (HS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for metformin in hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: K.R. van Straalen | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: COMPLETED